Investments in research and development for supplemental drug indications: implications for drug price negotiations

Vokinger, K. N., Perényi, G. & Wouters, O. J.ORCID logo (2023). Investments in research and development for supplemental drug indications: implications for drug price negotiations. JAMA Health Forum, 4(9), E232798. https://doi.org/10.1001/jamahealthforum.2023.2798
Copy
Item Type Article
Copyright holders © 2023 The Author(s)
Departments LSE > Academic Departments > Health Policy
DOI 10.1001/jamahealthforum.2023.2798
Date Deposited 06 Jul 2023
Acceptance Date 05 Jul 2023
URI https://researchonline.lse.ac.uk/id/eprint/119649

Explore Further

picture_as_pdf
subject
Published Version
Creative Commons: Attribution 4.0
Download

Export as

EndNote BibTeX Reference Manager Refer Atom Dublin Core JSON Multiline CSV
Export

Downloads
View more statistics